Propofol Sedation for Colonoscopy with a New Ultrathin or a Standard Endoscope: a Prospective Randomized Controlled Study

Not Applicable

• Conditions: Consumption of sedative drugs during colonoscopy; D12.8; K58.0; Rectum

• Registration Number: DRKS00004227
• Lead Sponsor: EVK Evangelisches Krankenhaus DüsseldorfMedizinische Klinik

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2012-01-27
• Study Start: 2012-07-04
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 203

Inclusion Criteria

Willingness to accept sedation on demand; ASA 1 or 2, age = 18 years; indication screening, anemia, history of polypectomy, suspected gastrointestinal bleeding, abdominal complaints, irregular bowel habits

Exclusion Criteria

Patiens without informed consent, who wish deep sedation from the beginning, who wish no sedation from the beginning, with a history of partial colectomy, with previously known colorectal carcinoma, with previously known inflammatory bowel disease, with pregnancy or breastfeeding, with scheduled polypectomy, ASA 3 or 4

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Consumption of propofol (mg) until colonoscope reaches caecum

Secondary Outcome Measures

Name	Time	Method
evel of sedation (definition according to the guidelines of the Deutsche Gesellschaft für Verdauungs- und Stoffwechselkrankheiten) while colonoscope is being pushed forward: <br>time 1 - colonoscope reaches colon transversum; time 2 - colonoscope reaches caecum.